Clinical Trials
75
Active:3
Completed:58
Trial Phases
5 Phases
Phase 1:8
Phase 2:5
Phase 3:16
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (66 trials with phase data)• Click on a phase to view related trials
Phase 4
32 (48.5%)Phase 3
16 (24.2%)Phase 1
8 (12.1%)Not Applicable
5 (7.6%)Phase 2
5 (7.6%)Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
Not Applicable
Not yet recruiting
- Conditions
- Influenza
- Interventions
- Biological: Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIVBiological: Vaxigrip QIV
- First Posted Date
- 2025-10-07
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT07211152
- Locations
- 🇵🇭
Health Cube Medical Clinics, Mandaluyong, National Capital Region, Philippines
🇵🇭University of the Philippines - Philippine General Hospital (UP-PGH), Manila, National Capital Region, Philippines
A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
Completed
- Conditions
- Pneumococcal Infectious Disease
- Interventions
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 19267
- Registration Number
- NCT07071701
- Locations
- 🇨🇳
Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, Jiangsu, China
Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
Not Applicable
Not yet recruiting
- Conditions
- Rabies
- Interventions
- Biological: Rabies Vaccine (Serum-free Vero Cell), Freeze-driedBiological: Verorab®
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT07055880
- Locations
- 🇵🇰
The Aga Khan University, Karachi, Pakistan
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen
Not Applicable
Not yet recruiting
- Conditions
- Rabies (Healthy Volunteers)
- Interventions
- Biological: Verorab®
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 390
- Registration Number
- NCT07055893
- Locations
- 🇵🇰
Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
Not Applicable
Not yet recruiting
- Conditions
- Rabies
- Interventions
- Biological: Rabies Vaccine (Serum-free Vero Cell), Freeze-driedBiological: Verorab®
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 390
- Registration Number
- NCT07055295
- Locations
- 🇵🇰
Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
No news found